Ann: OncoSil FY21 half yearly review, page-15

Reimbusement is based on economic cost benefit analysis including QOL analysis - usually it is compared to another treatment possibly standard radiotherapy. I agree someone with deep pockets would think of nothing spending on the procedure. Reimbursement will take some time it also depends on complex interplay in places like the USA with the hospitals and also the insurance groups once they have FDA approvals. I have also wondered why they did not set up some small implant centres with radiology gastro services and have a series of clinics that offer the implant services for the device - a bit like a cochlear model.